Literature DB >> 19049599

Energy metabolism as part of the anticonvulsant mechanism of the ketogenic diet.

Kristopher Bough1.   

Abstract

The efficacy of the ketogenic diet (KD) develops gradually over a period of 1-3 weeks, suggesting that adaptive changes in gene expression are involved in its anticonvulsant effects. Previously, microarrays were employed to define patterns of gene expression in the hippocampus of rats maintained on either a KD or a control diet for 3 weeks. The density of mitochondria in hippocampal tissue was assessed by electron microscopy. Levels of selected energy metabolites, enzyme activities, and the effect of low glucose on synaptic transmission were also investigated in hippocampal tissue taken from either KD- or control-fed animals. We found a coordinated up-regulation of transcripts encoding energy metabolism enzymes and a dramatic 46% increase in the density of mitochondria observed in neuronal processes. These changes were accompanied by an increased phosphocreatine (PCr):creatine (Cr) energy-store ratio. Consistent with heightened energy reserves, hippocampal synaptic transmission in KD-fed animals was maintained approximately 50% longer compared to controls after exposure to a mild metabolic stressor. Taken together, several lines of evidence indicate that the KD enhances energy production in the brain. As a consequence, brain tissue appears to become more resistant to metabolic stress. It is proposed...that the observed KD-induced enhancements in energy metabolism help to compensate for the metabolic deficits exhibited (interictally) within epileptic foci and transient failures of gamma-aminobutyric acid (GABA) ergic inhibition, which would otherwise favor the initiation and propagation of seizure activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19049599      PMCID: PMC3056236          DOI: 10.1111/j.1528-1167.2008.01846.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  14 in total

Review 1.  An energy budget for signaling in the grey matter of the brain.

Authors:  D Attwell; S B Laughlin
Journal:  J Cereb Blood Flow Metab       Date:  2001-10       Impact factor: 6.200

2.  A ketogenic diet has different effects upon seizures induced by maximal electroshock and by pentylenetetrazole infusion.

Authors:  K J Bough; P J Matthews; D A Eagles
Journal:  Epilepsy Res       Date:  2000-02       Impact factor: 3.045

3.  An animal model for the ketogenic diet.

Authors:  D B Appleton; D C DeVivo
Journal:  Epilepsia       Date:  1974-06       Impact factor: 5.864

Review 4.  Blood-brain barrier, ion homeostatis and epilepsy: possible implications towards the understanding of ketogenic diet mechanisms.

Authors:  D Janigro
Journal:  Epilepsy Res       Date:  1999-12       Impact factor: 3.045

Review 5.  Ketogenic diet, amino acid metabolism, and seizure control.

Authors:  M Yudkoff; Y Daikhin; I Nissim; A Lazarow; I Nissim
Journal:  J Neurosci Res       Date:  2001-12-01       Impact factor: 4.164

6.  Ketosis and epilepsy: 31P spectroscopic imaging at 4.1 T.

Authors:  J W Pan; E M Bebin; W J Chu; H P Hetherington
Journal:  Epilepsia       Date:  1999-06       Impact factor: 5.864

7.  Restricted neuronal expression of ubiquitous mitochondrial creatine kinase: changing patterns in development and with increased activity.

Authors:  J Boero; W Qin; J Cheng; T A Woolsey; A W Strauss; Z Khuchua
Journal:  Mol Cell Biochem       Date:  2003-02       Impact factor: 3.396

Review 8.  A key glycolytic enzyme plays a dual role in GABAergic neurotransmission and in human epilepsy.

Authors:  René Pumain; Jacques Laschet
Journal:  Crit Rev Neurobiol       Date:  2006

9.  GABAA-receptor function in hippocampal cells is maintained by phosphorylation factors.

Authors:  A Stelzer; A R Kay; R K Wong
Journal:  Science       Date:  1988-07-15       Impact factor: 47.728

10.  Calorie restriction and ketogenic diet diminish neuronal excitability in rat dentate gyrus in vivo.

Authors:  Kristopher J Bough; Philip A Schwartzkroin; Jong M Rho
Journal:  Epilepsia       Date:  2003-06       Impact factor: 5.864

View more
  28 in total

Review 1.  Astrocytic regulation of glutamate homeostasis in epilepsy.

Authors:  Douglas A Coulter; Tore Eid
Journal:  Glia       Date:  2012-05-16       Impact factor: 7.452

Review 2.  Mitochondrial energetics and therapeutics.

Authors:  Douglas C Wallace; Weiwei Fan; Vincent Procaccio
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

3.  The ketogenic diet is well tolerated and can be effective in patients with argininosuccinate lyase deficiency and refractory epilepsy.

Authors:  Rosanne Peuscher; Monique E Dijsselhof; Nico G Abeling; Margreet Van Rijn; Francjan J Van Spronsen; Annet M Bosch
Journal:  JIMD Rep       Date:  2011-12-25

4.  Triheptanoin for glucose transporter type I deficiency (G1D): modulation of human ictogenesis, cerebral metabolic rate, and cognitive indices by a food supplement.

Authors:  Juan M Pascual; Peiying Liu; Deng Mao; Dorothy I Kelly; Ana Hernandez; Min Sheng; Levi B Good; Qian Ma; Isaac Marin-Valencia; Xuchen Zhang; Jason Y Park; Linda S Hynan; Peter Stavinoha; Charles R Roe; Hanzhang Lu
Journal:  JAMA Neurol       Date:  2014-10       Impact factor: 18.302

5.  Altered expression of brain monocarboxylate transporter 1 in models of temporal lobe epilepsy.

Authors:  Fredrik Lauritzen; Edgar L Perez; Eric R Melillo; Jung-Min Roh; Hitten P Zaveri; Tih-Shih W Lee; Yue Wang; Linda H Bergersen; Tore Eid
Journal:  Neurobiol Dis       Date:  2011-08-10       Impact factor: 5.996

6.  Decreased astroglial monocarboxylate transporter 4 expression in temporal lobe epilepsy.

Authors:  Bei Liu; Le Niu; Ming-Zhi Shen; Lei Gao; Chao Wang; Jie Li; Li-Jia Song; Ye Tao; Qiang Meng; Qian-Li Yang; Guo-Dong Gao; Hua Zhang
Journal:  Mol Neurobiol       Date:  2014-01-25       Impact factor: 5.590

7.  Heptanoate as a neural fuel: energetic and neurotransmitter precursors in normal and glucose transporter I-deficient (G1D) brain.

Authors:  Isaac Marin-Valencia; Levi B Good; Qian Ma; Craig R Malloy; Juan M Pascual
Journal:  J Cereb Blood Flow Metab       Date:  2012-10-17       Impact factor: 6.200

8.  Ketogenic diet prevents epileptogenesis and disease progression in adult mice and rats.

Authors:  Theresa A Lusardi; Kiran K Akula; Shayla Q Coffman; David N Ruskin; Susan A Masino; Detlev Boison
Journal:  Neuropharmacology       Date:  2015-08-06       Impact factor: 5.250

Review 9.  Adenosine kinase: exploitation for therapeutic gain.

Authors:  Detlev Boison
Journal:  Pharmacol Rev       Date:  2013-04-16       Impact factor: 25.468

10.  Partial Amelioration of Peripheral and Central Symptoms of Huntington's Disease via Modulation of Lipid Metabolism.

Authors:  Jane Y Chen; Conny Tran; Lin Hwang; Gang Deng; Michael E Jung; Kym F Faull; Michael S Levine; Carlos Cepeda
Journal:  J Huntingtons Dis       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.